Register entry
Shandong Apeloa Tospo Pharmaceutical Co., Ltd.
Data as of · How to read this entry
- Registered sites
- 1
- Active NDC listings
- 0
- Live patents
- 0
- Countries
- 1
- Base
- China
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Shandong Apeloa Tospo Pharmaceutical Co., Ltd. | No. 08667 Lingang Road, Lingang Industrial Park, Binhai Economic and Technological Development Zone, Weifang, Shandong 262737, China (CHN) | Active ingredient (API) manufacture | 3013594022545084025 |
Neighbours
Registered in the same town
4- Shandong AZC Biotechnology Co., Ltd.Weifang, CHN
- Shandong Guobang Pharmaceutical Co., Ltd.Weifang, CHN
- Weifang Shengtai Medicine Co. , Ltd.Weifang, CHN
- Zhongfu Pharmaceutical Co LtdWeifang, CHN
Compare
Comparable companies in China
- Qingdao Biopeptek Co Ltd1 site · 110 NDC
- Zhejiang Ausun Pharmaceutical Co., Ltd.1 site · 55 NDC
- Hubei Gedian Humanwell Pharmaceutical Co., Ltd1 site · 31 NDC
- Shandong New Time Pharmaceutical Co., Ltd.1 site · 29 NDC
- Anqiu Lu'an Pharmaceutical Co., Ltd.1 site · 27 NDC
- Hainan Poly Pharm. Co., Ltd.1 site · 27 NDC
- Shenzhen Alvantis Pharma Co., Ltd.1 site · 27 NDC
- El-Peptido (Shanghai) Biopharmaceutical Co., Ltd1 site · 25 NDC
- Amphastar Nanjing Pharmaceuticals, Inc.1 site · 24 NDC
- Zhejiang Apeloa Jiayuan Pharmaceutical Co Ltd1 site · 23 NDC
Enquiry
Common questions
- Is Shandong Apeloa Tospo Pharmaceutical Co., Ltd. FDA approved?
- Shandong Apeloa Tospo Pharmaceutical Co., Ltd. holds 1 FDA-registered establishment in China. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Shandong Apeloa Tospo Pharmaceutical Co., Ltd.'s drugs manufactured?
- The FDA register lists Weifang. Registered operations: active ingredient (API) manufacture.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.